サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1251973

リポソームの世界市場：標的ドラッグデリバリーシステムに対する需要の向上が市場を促進

Rising Demand for Targeted Drug Delivery Systems Boosting Liposomes Market
出版日: | 発行: Persistence Market Research | ページ情報: 英文 201 Pages | 納期: 2～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
リポソームの世界市場：標的ドラッグデリバリーシステムに対する需要の向上が市場を促進
出版日: 2023年02月27日
発行: Persistence Market Research
ページ情報: 英文 201 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のリポソーム市場について調査分析し、市場動向、地域とセグメントごとの分析と予測、競合分析などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の概要

  • 市場の範囲/分類法
  • 市場の定義/範囲/制限
  • 包含と除外

第3章 主な市場の動向

  • 市場に影響を与える主な動向
  • 製品のイノベーション/開発の動向

第4章 主な成功要因

  • プロモーション戦略：メーカー別
  • 製品採用率 - 主な統計
  • パイプラインの評価
  • 規制シナリオ
  • PESTEL分析
  • ポーターのファイブフォース分析

第5章 市場の背景

  • マクロ経済要因
    • 世界のGDP成長の見通し
    • 世界の医療の見通し
    • 世界のドラッグデリバリーシステム市場の見通し
  • 予測要因 - 関連性と影響
    • 慢性疾患の有病率
    • リポソーム薬品の需要の高まり
    • 多様な医薬品用途に向けたナノ担体としての広い採用
    • 研究開発活動の増加
    • 技術の進歩
    • 合併と買収
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会の分析

第6章 COVID-19危機の分析

  • COVID-19と影響の分析
    • 製品別
    • 用途別
    • 流通チャネル別
    • 地域別
  • 市場シナリオ（2022年）

第7章 世界市場の需要の分析と予測

  • 過去の市場の分析
  • 現在と将来の市場の分析と予測
    • 前年比成長動向の分析

第8章 世界市場の分析と予測：製品別

  • イントロダクション/主な調査結果
  • 過去の市場の分析：製品別
  • 現在と将来の市場の分析と予測：製品別
    • 単純リポソーム
    • 処方リポソーム
    • ワクチン
  • 市場魅力の分析：製品別

第9章 世界市場の分析と予測：用途別

  • イントロダクション/主な調査結果
  • 過去の市場の分析：用途別
  • 現在と将来の市場の分析と予測：用途別
    • ドラッグデリバリー
    • 遺伝子デリバリー/トランスフェクション
    • 医用画像向け造影剤
    • モデル細胞膜
  • 市場魅力の分析：用途別

第10章 世界市場の分析と予測：流通チャネル別

  • イントロダクション/主な調査結果
  • 過去の市場の分析：流通チャネル別
  • 現在と将来の市場の分析と予測：流通チャネル別
    • 小売販売
    • 流通販売
  • 市場魅力の分析：流通チャネル別

第11章 世界市場の分析と予測：地域別

  • イントロダクション
  • 過去の市場の分析：地域別
  • 現在と将来の市場の分析と予測：地域別
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ
  • 市場魅力の分析：地域別

第12章 北米市場の分析と予測

  • イントロダクション
  • 過去の市場動向の分析：市場分類別
  • 現在と将来の市場の分析と予測：市場分類別
    • 国別
    • 製品別
    • 用途別
    • 流通チャネル別
  • 市場魅力の分析
    • 国別
    • 製品別
    • 用途別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因 - 影響の分析
  • 国レベルの分析と予測
    • 米国市場の分析
    • カナダ市場の分析

第13章 ラテンアメリカ市場の分析と予測

  • イントロダクション
  • 過去の市場動向の分析：市場分類別
  • 現在と将来の市場の分析と予測：市場分類別
    • 国別
    • 製品別
    • 用途別
    • 流通チャネル別
  • 市場魅力の分析
    • 国別
    • 製品別
    • 用途別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因 - 影響の分析
  • 国レベルの分析と予測
    • メキシコ市場の分析
    • ブラジル市場の分析
    • アルゼンチン市場の分析

第14章 欧州市場の分析と予測

  • イントロダクション
  • 過去の市場動向の分析：市場分類別
  • 現在と将来の市場の分析と予測：市場分類別
    • 国別
    • 製品別
    • 用途別
    • 流通チャネル別
  • 市場魅力の分析
    • 国別
    • 製品別
    • 用途別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因 - 影響の分析
  • 国レベルの分析と予測
    • ドイツ市場の分析
    • イタリア市場の分析
    • フランス市場の分析
    • 英国市場の分析
    • スペイン市場の分析
    • ベネルクス市場の分析
    • ロシア市場の分析

第15章 東アジア市場の分析と予測

  • イントロダクション
  • 過去の市場の流通チャネルトレンド分析：市場分類別
  • 現在と将来の市場の分析と予測：市場分類別
    • 国別
    • 製品別
    • 用途別
    • 流通チャネル別
  • 市場魅力の分析
    • 製品別
    • 用途別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因 - 影響の分析
  • 国レベルの分析と予測
    • 中国市場の分析
    • 日本市場の分析
    • 韓国市場の分析

第16章 南アジア市場の分析と予測

  • イントロダクション
  • 過去の市場動向の分析：市場分類別
  • 現在と将来の市場の分析と予測：市場分類別
    • 国別
    • 製品別
    • 用途別
    • 流通チャネル別
  • 市場魅力の分析
    • 国別
    • 製品別
    • 用途別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因 - 影響の分析
  • 国レベルの分析と予測
    • インド市場の分析
    • インドネシア市場の分析
    • マレーシア市場の分析
    • タイ市場の分析

第17章 オセアニアの市場と予測

  • イントロダクション
  • 過去の市場動向の分析：市場分類別
  • 現在と将来の市場の分析と予測：市場分類別
    • 国別
    • 製品別
    • 用途別
    • 流通チャネル別
  • 市場魅力の分析
    • 国別
    • 製品別
    • 用途別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因 - 影響の分析
  • 国レベルの分析と予測
    • オーストラリア市場の分析
    • ニュージーランド市場の分析

第18章 中東・アフリカ市場の分析と予測

  • イントロダクション
  • 過去の市場動向の分析：市場分類別
  • 現在と将来の市場の分析と予測：市場分類別
    • 国別
    • 製品別
    • 用途別
    • 流通チャネル別
  • 市場魅力の分析
    • 製品別
    • 用途別
    • 流通チャネル別
  • 市場動向
  • 促進要因と抑制要因 - 影響の分析
  • 国レベルの分析と予測
    • GCC諸国の市場の分析
    • トルコ市場の分析
    • 南アフリカ市場の分析
    • 北アフリカ市場の分析

第19章 市場構造分析

  • 市場の分析：企業の階層別
  • 主要企業の市場シェアの分析
  • 市場プレゼンス分析

第20章 競合分析

  • 競合ダッシュボード
  • ブランディングとプロモーション戦略
  • 主な開発の分析
  • 競合の詳細
    • Novartis AG (Liposoma BV)
    • Precision NanoSystems Inc
    • Janssen Pharmaceutical Companies (Johnson & Johnson)
    • Encapsula Nano Sciences
    • Synpac-Kingdom Pharmaceutical Co., Ltd
    • Celsion GmbH
    • Gilead Sciences, Inc
    • Pacira BioSciences, Inc.
    • Luye Pharma Group
    • Sun Pharma Industries Ltd
    • Shanghai New Asia Pharmaceutical Co., Ltd.
    • ENERGY DELIVERY SOLUTIONs
    • Creative Biolabs
    • Nanovex Biotechnologies SL
    • Insys Therapeutics Inc
    • Fujifilm Holdings Corporation
    • Virpax Pharmaceuticals
    • Azaya Therapeutics
    • Avanti Polar Lipids, Inc.
    • Breath Therapeutics (Zambon company)
    • Getwell
    • Taiwan Liposome Company Ltd
    • Fresenius Health Care Group
    • Xellia Pharmaceuticals (Novo Holdings A/S)
    • Jazz Pharmaceuticals plc
    • Ipsen Biopharmaceuticals, Inc.
    • Baxter
    • GMPriority Pharma
    • S. G. Biopharm Pvt. Ltd

第21章 使用される前提条件と頭字語

第22章 調査手法

図表

List of Tables

  • Table 01: Global Liposomes Market Analysis 2015-2022 and Forecast 2023-2033, by Product
  • Table 02: Global Liposomes Market Analysis 2015-2022 and Forecast 2023-2033by Application
  • Table 03: Global Liposomes Market Analysis 2015-2022 and Forecast 2023-2033, by Distribution Channel
  • Table 04: Global Liposomes Market Analysis 2015-2022 and Forecast 2023-2033, by Region
  • Table 05: North America Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 06: North America Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
  • Table 07: North America Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Application
  • Table 08: North America Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution Channel
  • Table 09: Latin America Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 10: Latin America Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
  • Table 11: Latin America Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Application
  • Table 12: Latin America Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution Channel
  • Table 13: Europe Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 14: Europe Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
  • Table 15: Europe Liposomes Market Analysis 2015-2022 and Forecast 2023-2033by Application
  • Table 16: Europe Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution Channel
  • Table 17: East Asia Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 18: East Asia Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
  • Table 19: East Asia Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Application
  • Table 20: East Asia Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution Channel
  • Table 21: South Asia Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 22: South Asia Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
  • Table 23: South Asia Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Application
  • Table 24: South Asia Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution Channel
  • Table 25: Oceania Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 26: Oceania Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
  • Table 27: Oceania Liposomes Market Analysis 2015-2022 and Forecast 2023-2033by Application
  • Table 28: Oceania Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution Channel
  • Table 29: Middle East & Africa Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 30: Middle East & Africa Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Product
  • Table 31: Middle East & Africa Liposomes Market Analysis 2015-2022 and Forecast 2023-2033 by Application
  • Table 32: Middle East & Africa Liposomes Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution Channel

List of Figures

  • Figure 01: Global Liposomes Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 02: Global Liposomes Market Forecast & Y-o-Y Growth, 2023-2033
  • Figure 03: Global Liposomes Market Absolute $ Opportunity (US$ Mn) Analysis, 2022-2033
  • Figure 04: Global Liposomes Market Value Share (%) Analysis 2023 and 2033, by Product
  • Figure 05: Global Liposomes Market Y-o-Y Growth (%) Analysis 2022-2033, by Product
  • Figure 06: Global Liposomes Market Attractiveness Analysis 2023-2033, by Product
  • Figure 07: Global Liposomes Market Value Share (%) Analysis 2023 and 2033, by Application
  • Figure 08: Global Liposomes Market Y-o-Y Growth (%) Analysis 2022-2033, by Application
  • Figure 09: Global Liposomes Market Attractiveness Analysis 2023-2033, by Application
  • Figure 10: Global Liposomes Market Value Share (%) Analysis 2023 and 2033, by Distribution Channel
  • Figure 11: Global Liposomes Market Y-o-Y Growth (%) Analysis 2022-2033, by Distribution Channel
  • Figure 12: Global Liposomes Market Attractiveness Analysis 2023-2033, by Distribution Channel
  • Figure 13: Global Liposomes Market Value Share (%) Analysis 2023 and 2033, by Region
  • Figure 14: Global Liposomes Market Y-o-Y Growth (%) Analysis 2022-2033, by Region
  • Figure 15: Global Liposomes Market Attractiveness Analysis 2023-2033, by Region
  • Figure 16: North America Liposomes Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 17: North America Liposomes Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 18: North America Liposomes Market Value Share, by Product (2023 E)
  • Figure 19: North America Liposomes Market Value Share, by Application (2023 E)
  • Figure 20: North America Liposomes Market Value Share, by Distribution Channel (2023 E)
  • Figure 21: North America Liposomes Market Value Share, by Country (2023 E)
  • Figure 22: North America Liposomes Market Attractiveness Analysis by Product, 2023-2033
  • Figure 23: North America Liposomes Market Attractiveness Analysis by Application, 2023-2033
  • Figure 24: North America Liposomes Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 25: North America Liposomes Market Attractiveness Analysis by Country, 2023-2033
  • Figure 26: U.S. Liposomes Market Value Proportion Analysis, 2022
  • Figure 27: Global Vs. U.S. Growth Comparison
  • Figure 28: U.S. Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 29: U.S. Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 30: U.S. Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 31: Canada Liposomes Market Value Proportion Analysis, 2022
  • Figure 32: Global Vs. Canada. Growth Comparison
  • Figure 33: Canada Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 34: Canada Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 35: Canada Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 36: Latin America Liposomes Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 37: Latin America Liposomes Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 38: Latin America Liposomes Market Value Share, by Product (2023 E)
  • Figure 39: Latin America Liposomes Market Value Share, by Application (2023 E)
  • Figure 40: Latin America Liposomes Market Value Share, by Distribution Channel (2023 E)
  • Figure 41: Latin America Liposomes Market Value Share, by Country (2023 E)
  • Figure 42: Latin America Liposomes Market Attractiveness Analysis by Product, 2023-2033
  • Figure 43: Latin America Liposomes Market Attractiveness Analysis by Application, 2023-2033
  • Figure 44: Latin America Liposomes Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 45: Latin America Liposomes Market Attractiveness Analysis by Country, 2023-2033
  • Figure 46: Mexico Liposomes Market Value Proportion Analysis, 2022
  • Figure 47: Global Vs Mexico Growth Comparison
  • Figure 48: Mexico Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 49: Mexico Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 50: Mexico Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 51: Brazil Liposomes Market Value Proportion Analysis, 2022
  • Figure 52: Global Vs. Brazil. Growth Comparison
  • Figure 53: Brazil Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 54: Brazil Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 55: Brazil Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 56: Argentina Liposomes Market Value Proportion Analysis, 2022
  • Figure 57: Global Vs Argentina Growth Comparison
  • Figure 58: Argentina Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 59: Argentina Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 60: Argentina Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 61: Europe Liposomes Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 62: Europe Liposomes Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 63: Europe Liposomes Market Value Share, by Product (2023 E)
  • Figure 64: Europe Liposomes Market Value Share, by Application (2023 E)
  • Figure 65: Europe Liposomes Market Value Share, by Distribution Channel (2023 E)
  • Figure 66: Europe Liposomes Market Value Share, by Country (2023 E)
  • Figure 67: Europe Liposomes Market Attractiveness Analysis by Product, 2023-2033
  • Figure 68: Europe Liposomes Market Attractiveness Analysis by Application, 2023-2033
  • Figure 69: Europe Liposomes Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 70: Europe Liposomes Market Attractiveness Analysis by Country, 2023-2033
  • Figure 71: UK Liposomes Market Value Proportion Analysis, 2022
  • Figure 72: Global Vs. UK Growth Comparison
  • Figure 73: UK Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 74: UK Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 75: UK Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 76: Germany Liposomes Market Value Proportion Analysis, 2022
  • Figure 77: Global Vs. Germany Growth Comparison
  • Figure 78: Germany Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 79: Germany Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 80: Germany Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 81: Italy Liposomes Market Value Proportion Analysis, 2022
  • Figure 82: Global Vs. Italy Growth Comparison
  • Figure 83: Italy Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 84: Italy Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 85: Italy Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 86: France Liposomes Market Value Proportion Analysis, 2022
  • Figure 87: Global Vs France Growth Comparison
  • Figure 88: France Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 89: France Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 90: France Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 91: Spain Liposomes Market Value Proportion Analysis, 2022
  • Figure 92: Global Vs Spain Growth Comparison
  • Figure 93: Spain Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 94: Spain Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 95: Spain Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 96: Russia Liposomes Market Value Proportion Analysis, 2022
  • Figure 97: Global Vs Russia Growth Comparison
  • Figure 98: Russia Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 99: Russia Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 100: Russia Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 101: BENELUX Liposomes Market Value Proportion Analysis, 2022
  • Figure 102: Global Vs BENELUX Growth Comparison
  • Figure 103: BENELUX Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 104: BENELUX Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 105: BENELUX Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 106: East Asia Liposomes Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 107: East Asia Liposomes Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 108: East Asia Liposomes Market Value Share, by Product (2023 E)
  • Figure 109: East Asia Liposomes Market Value Share, by Application (2023 E)
  • Figure 110: East Asia Liposomes Market Value Share, by Distribution Channel (2023 E)
  • Figure 111: East Asia Liposomes Market Value Share, by Country (2023 E)
  • Figure 112: East Asia Liposomes Market Attractiveness Analysis by Product, 2023-2033
  • Figure 113: East Asia Liposomes Market Attractiveness Analysis by Application, 2023-2033
  • Figure 114: East Asia Liposomes Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 115: East Asia Liposomes Market Attractiveness Analysis by Country, 2023-2033
  • Figure 116: China Liposomes Market Value Proportion Analysis, 2022
  • Figure 117: Global Vs. China Growth Comparison
  • Figure 118: China Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 119: China Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 120: China Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 121: Japan Liposomes Market Value Proportion Analysis, 2022
  • Figure 122: Global Vs. Japan Growth Comparison
  • Figure 123: Japan Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 124: Japan Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 125: Japan Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 126: South Korea Liposomes Market Value Proportion Analysis, 2022
  • Figure 127: Global Vs South Korea Growth Comparison
  • Figure 128: South Korea Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 129: South Korea Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 130: South Korea Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 131: South Asia Liposomes Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 132: South Asia Liposomes Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 133: South Asia Liposomes Market Value Share, by Product (2023 E)
  • Figure 134: South Asia Liposomes Market Value Share, by Application (2023 E)
  • Figure 135: South Asia Liposomes Market Value Share, by Distribution Channel (2023 E)
  • Figure 136: South Asia Liposomes Market Value Share, by Country (2023 E)
  • Figure 137: South Asia Liposomes Market Attractiveness Analysis by Product, 2023-2033
  • Figure 138: South Asia Liposomes Market Attractiveness Analysis by Application, 2023-2033
  • Figure 139: South Asia Liposomes Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 140: South Asia Liposomes Market Attractiveness Analysis by Country, 2023-2033
  • Figure 141: India Liposomes Market Value Proportion Analysis, 2022
  • Figure 142: Global Vs. India Growth Comparison
  • Figure 143: India Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 144: India Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 145: India Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 146: Indonesia Liposomes Market Value Proportion Analysis, 2022
  • Figure 147: Global Vs. Indonesia Growth Comparison
  • Figure 148: Indonesia Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 149: Indonesia Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 150: Indonesia Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 151: Malaysia Liposomes Market Value Proportion Analysis, 2022
  • Figure 152: Global Vs. Malaysia Growth Comparison
  • Figure 153: Malaysia Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 154: Malaysia Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 155: Malaysia Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 156: Thailand Liposomes Market Value Proportion Analysis, 2022
  • Figure 157: Global Vs. Thailand Growth Comparison
  • Figure 158: Thailand Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 159: Thailand Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 160: Thailand Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 161: Oceania Liposomes Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 162: Oceania Liposomes Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 163: Oceania Liposomes Market Value Share, by Product (2023 E)
  • Figure 164: Oceania Liposomes Market Value Share, by Application (2023 E)
  • Figure 165: Oceania Liposomes Market Value Share, by Distribution Channel (2023 E)
  • Figure 166: Oceania Liposomes Market Value Share, by Country (2023 E)
  • Figure 167: Oceania Liposomes Market Attractiveness Analysis by Product, 2023-2033
  • Figure 168: Oceania Liposomes Market Attractiveness Analysis by Application, 2023-2033
  • Figure 169: Oceania Liposomes Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 170: Oceania Liposomes Market Attractiveness Analysis by Country, 2023-2033
  • Figure 171: Australia Liposomes Market Value Proportion Analysis, 2022
  • Figure 172: Global Vs. Australia Growth Comparison
  • Figure 173: Australia Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 174: Australia Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 175: Australia Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 176: New Zealand Liposomes Market Value Proportion Analysis, 2022
  • Figure 177: Global Vs New Zealand Growth Comparison
  • Figure 178: New Zealand Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 179: New Zealand Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 180: New Zealand Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 181: Middle East & Africa Liposomes Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 182: Middle East & Africa Liposomes Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 183: Middle East & Africa Liposomes Market Value Share, by Product (2023 E)
  • Figure 184: Middle East & Africa Liposomes Market Value Share, by Application (2023 E)
  • Figure 185: Middle East & Africa Liposomes Market Value Share, by Distribution Channel (2023 E)
  • Figure 186: Middle East & Africa Liposomes Market Value Share, by Country (2023 E)
  • Figure 187: Middle East & Africa Liposomes Market Attractiveness Analysis by Product, 2023-2033
  • Figure 188: Middle East & Africa Liposomes Market Attractiveness Analysis by Application, 2023-2033
  • Figure 189: Middle East & Africa Liposomes Market Attractiveness Analysis by Distribution Channel, 2023-2033
  • Figure 190: Middle East & Africa Liposomes Market Attractiveness Analysis by Country, 2023-2033
  • Figure 191: GCC Countries Liposomes Market Value Proportion Analysis, 2022
  • Figure 192: Global Vs GCC Countries Growth Comparison
  • Figure 193: GCC Countries Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 194: GCC Countries Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 195: GCC Countries Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 196: Turkiye Liposomes Market Value Proportion Analysis, 2022
  • Figure 197: Global Vs. Turkiye Growth Comparison
  • Figure 198: Turkiye Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 199: Turkiye Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 200: Turkiye Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 201: South Africa Liposomes Market Value Proportion Analysis, 2022
  • Figure 202: Global Vs. South Africa Growth Comparison
  • Figure 203: South Africa Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 204: South Africa Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 205: South Africa Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
  • Figure 206: North Africa Liposomes Market Value Proportion Analysis, 2022
  • Figure 207: Global Vs North Africa Growth Comparison
  • Figure 208: North Africa Liposomes Market Share Analysis (%) by Product, 2023 & 2033
  • Figure 209: North Africa Liposomes Market Share Analysis (%) by Application, 2023 & 2033
  • Figure 210: North Africa Liposomes Market Share Analysis (%) by Distribution Channel, 2023 & 2033
目次
Product Code: PMRREP16546

Liposomes Market: Scope of the Report

The latest publication by Persistence Market Research on the global liposomes market evaluates the opportunities and current market landscape and provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023-2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for liposomes and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the liposomes market. Shareholders in the liposomes market, industry experts, investors, researchers, and reporters, as well as business enthusiasts, can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as macroeconomic variables affecting the business scenario in the liposomes market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the liposomes market offers information divided into four important segments - product, application, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product

Simple Liposomes

Formulated Liposomes

Doxorubicin Liposomes

Amphotericin B Liposomes

Paclitaxel Liposomes

Cytarabine Liposomes

Irinotecan Liposomes

Cisplatin Liposomes

Others

Vaccines

Application

Drug delivery

Cancer

Fungal Infection

Viral & Parasite Infection

Others

Gene Delivery/Transfection

Contrast agents for medical imaging

Model Cell Membranes

Distribution Channel

Retail Sales

Academic & Research Laboratories

Biopharmaceutical Companies

Clinical Research Organizations

Others

Distributional Sales

Hospital Pharmacies

Retail Pharmacies

Mail Order Pharmacies

Drug Stores

Region

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East and Africa (MEA)

Key Questions Answered in Report:

Which regions will continue to remain the most profitable markets for liposomes over the coming years?

How will changing trends influence the market?

How has the COVID-19 crisis influenced market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will influence the market?

How can companies in the liposomes market avail themselves of the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the liposomes market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research's projections on the growth prospects of the liposomes market are more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Promotional Strategies - By Manufacturers
  • 4.2. Product Adoption Rate - Key Statistics
  • 4.3. Pipeline Assessment
  • 4.4. Regulatory Scenario
  • 4.5. PESTEL Analysis
  • 4.6. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Drug Delivery Systems Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Prevalence of Chronic Diseases
    • 5.2.2. Growing Demand for Liposomal Drugs
    • 5.2.3. Widespread Adoption as Nano - Carriers for Diverse Pharmaceutical Applications
    • 5.2.4. Increasing Research and Development Activities
    • 5.2.5. Technological Advancements
    • 5.2.6. Merger and Acquisitions
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Application
    • 6.1.3. By Distribution Channel
    • 6.1.4. By Region
  • 6.2. 2022 Market Scenario

7. Global Market Demand (in Value US$ Mn) Analysis 2015-2022 and Forecast, 2023-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2022
  • 7.2. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2015-2022 and Forecast 2023-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis, by Product, 2015-2022
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Product, 2023-2033
    • 8.3.1. Simple Liposomes
    • 8.3.2. Formulated Liposomes
      • 8.3.2.1. Doxorubicin Liposomes
      • 8.3.2.2. Amphotericin B Liposomes
      • 8.3.2.3. Paclitaxel Liposomes
      • 8.3.2.4. Cytarabine Liposomes
      • 8.3.2.5. Irinotecan Liposomes
      • 8.3.2.6. Cisplatin Liposomes
      • 8.3.2.7. Others
    • 8.3.3. Vaccines
  • 8.4. Market Attractiveness Analysis, by Product

9. Global Market Analysis 2015-2022 and Forecast 2023-2033, By Application

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Application, 2015-2022
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Application, 2023-2033
    • 9.3.1. Drug delivery
      • 9.3.1.1. Cancer
      • 9.3.1.2. Fungal Infection
      • 9.3.1.3. Viral & Parasite Infection
      • 9.3.1.4. Others
    • 9.3.2. Gene Delivery/Transfection
    • 9.3.3. Contrast agents for medical imaging
    • 9.3.4. Model Cell Membranes
  • 9.4. Market Attractiveness Analysis, by Application

10. Global Market Analysis 2015-2022 and Forecast 2023-2033, By Distribution Channel

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2015-2022
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Distribution Channel, 2023-2033
    • 10.3.1. Retail Sales
      • 10.3.1.1. Academic & Research Laboratories
      • 10.3.1.2. Biopharmaceutical Companies
      • 10.3.1.3. Clinical Research Organizations
      • 10.3.1.4. Others
    • 10.3.2. Distributional Sales
      • 10.3.2.1. Hospital Pharmacies
      • 10.3.2.2. Retail Pharmacies
      • 10.3.2.3. Mail Order Pharmacies
      • 10.3.2.4. Drug Stores
  • 10.4. Market Attractiveness Analysis, by Distribution Channel

11. Global Market Analysis 2015-2022 and Forecast 2023-2033, By Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis, by Region, 2015-2022
  • 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Region 2023-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis, by Region

12. North America Market Analysis 2015-2022 and Forecast 2023-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2015-2022
  • 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 2023-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Product
    • 12.3.3. By Application
    • 12.3.4. By Distribution Channel
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By Application
    • 12.4.4. By Distribution Channel
  • 12.5. Market Trends
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Country Level Analysis & Forecast
    • 12.7.1. U.S. Market Analysis
      • 12.7.1.1. Introduction
      • 12.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.7.1.2.1. By Product
        • 12.7.1.2.2. By Application
        • 12.7.1.2.3. By Distribution Channel
    • 12.7.2. Canada Market Analysis
      • 12.7.2.1. Introduction
      • 12.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.7.2.2.1. By Product
        • 12.7.2.2.2. By Application
        • 12.7.2.2.3. By Distribution Channel

13. Latin America Market Analysis 2015-2022 and Forecast 2023-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2015-2022
  • 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 2023-2033
    • 13.3.1. By Country
      • 13.3.1.1. Mexico
      • 13.3.1.2. Brazil
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Product
    • 13.3.3. By Application
    • 13.3.4. By Distribution Channel
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Application
    • 13.4.4. By Distribution Channel
  • 13.5. Market Trends
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Country Level Analysis & Forecast
    • 13.7.1. Mexico Market Analysis
      • 13.7.1.1. Introduction
      • 13.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.1.2.1. By Product
        • 13.7.1.2.2. By Application
        • 13.7.1.2.3. By Distribution Channel
    • 13.7.2. Brazil Market Analysis
      • 13.7.2.1. Introduction
      • 13.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.2.2.1. By Product
        • 13.7.2.2.2. By Application
        • 13.7.2.2.3. By Distribution Channel
    • 13.7.3. Argentina Market Analysis
      • 13.7.3.1. Introduction
      • 13.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.7.3.2.1. By Product
        • 13.7.3.2.2. By Application
        • 13.7.3.2.3. By Distribution Channel

14. Europe Market Analysis 2015-2022 and Forecast 2023-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2015-2022
  • 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 2023-2033
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Product
    • 14.3.3. By Application
    • 14.3.4. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Application
    • 14.4.4. By Distribution Channel
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. Germany Market Analysis
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.1.2.1. By Product
        • 14.7.1.2.2. By Application
        • 14.7.1.2.3. By Distribution Channel
    • 14.7.2. Italy Market Analysis
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.2.2.1. By Product
        • 14.7.2.2.2. By Application
        • 14.7.2.2.3. By Distribution Channel
    • 14.7.3. France Market Analysis
      • 14.7.3.1. Introduction
      • 14.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.3.2.1. By Product
        • 14.7.3.2.2. By Application
        • 14.7.3.2.3. By Distribution Channel
    • 14.7.4. U.K. Market Analysis
      • 14.7.4.1. Introduction
      • 14.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.4.2.1. By Product
        • 14.7.4.2.2. By Application
        • 14.7.4.2.3. By Distribution Channel
    • 14.7.5. Spain Market Analysis
      • 14.7.5.1. Introduction
      • 14.7.5.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.5.2.1. By Product
        • 14.7.5.2.2. By Application
        • 14.7.5.2.3. By Distribution Channel
    • 14.7.6. BENELUX Market Analysis
      • 14.7.6.1. Introduction
      • 14.7.6.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.6.2.1. By Product
        • 14.7.6.2.2. By Application
        • 14.7.6.2.3. By Distribution Channel
    • 14.7.7. Russia Market Analysis
      • 14.7.7.1. Introduction
      • 14.7.7.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.7.7.2.1. By Product
        • 14.7.7.2.2. By Application
        • 14.7.7.2.3. By Distribution Channel

15. East Asia Market Analysis 2015-2022 and Forecast 2023-2033

  • 15.1. Introduction
  • 15.2. Historical Market Distribution Channel (US$ Mn) Trend Analysis, by Market Taxonomy, 2015-2022
  • 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 2023-2033
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Product
    • 15.3.3. By Application
    • 15.3.4. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Product
    • 15.4.2. By Application
    • 15.4.3. By Distribution Channel
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. China Market Analysis
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.1.2.1. By Product
        • 15.7.1.2.2. By Application
        • 15.7.1.2.3. By Distribution Channel
    • 15.7.2. Japan Market Analysis
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.2.2.1. By Product
        • 15.7.2.2.2. By Application
        • 15.7.2.2.3. By Distribution Channel
    • 15.7.3. South Korea Market Analysis
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.7.3.2.1. By Product
        • 15.7.3.2.2. By Application
        • 15.7.3.2.3. By Distribution Channel

16. South Asia Market Analysis 2015-2022 and Forecast 2023-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2015-2022
  • 16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 2023-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Product
    • 16.3.3. By Application
    • 16.3.4. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Application
    • 16.4.4. By Distribution Channel
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. India Market Analysis
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.1.2.1. By Product
        • 16.7.1.2.2. By Application
        • 16.7.1.2.3. By Distribution Channel
    • 16.7.2. Indonesia Market Analysis
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.2.2.1. By Product
        • 16.7.2.2.2. By Application
        • 16.7.2.2.3. By Distribution Channel
    • 16.7.3. Malaysia Market Analysis
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.3.2.1. By Product
        • 16.7.3.2.2. By Application
        • 16.7.3.2.3. By Distribution Channel
    • 16.7.4. Thailand Market Analysis
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.7.4.2.1. By Product
        • 16.7.4.2.2. By Application
        • 16.7.4.2.3. By Distribution Channel

17. Oceania Market 2012-2021 and Forecast 2022-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2015-2022
  • 17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 2023-2033
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Product
    • 17.3.3. By Application
    • 17.3.4. By Distribution Channel
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Application
    • 17.4.4. By Distribution Channel
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. Australia Market Analysis
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.1.2.1. By Product
        • 17.7.1.2.2. By Application
        • 17.7.1.2.3. By Distribution Channel
    • 17.7.2. New Zealand Market Analysis
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.7.2.2.1. By Product
        • 17.7.2.2.2. By Application
        • 17.7.2.2.3. By Distribution Channel

18. Middle East and Africa (MEA) Market Analysis 2015-2022 and Forecast 2023-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2015-2022
  • 18.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 2023-2033
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkiye
      • 18.3.1.3. South Africa
      • 18.3.1.4. North Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Product
    • 18.3.3. By Application
    • 18.3.4. By Distribution Channel
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Product
    • 18.4.2. By Application
    • 18.4.3. By Distribution Channel
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. GCC Countries Market Analysis
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.1.2.1. By Product
        • 18.7.1.2.2. By Application
        • 18.7.1.2.3. By Distribution Channel
    • 18.7.2. Turkiye Market Analysis
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.2.2.1. By Product
        • 18.7.2.2.2. By Application
        • 18.7.2.2.3. By Distribution Channel
    • 18.7.3. South Africa Market Analysis
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.3.2.1. By Product
        • 18.7.3.2.2. By Application
        • 18.7.3.2.3. By Distribution Channel
    • 18.7.4. North Africa Market Analysis
      • 18.7.4.1. Introduction
      • 18.7.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.7.4.2.1. By Product
        • 18.7.4.2.2. By Application
        • 18.7.4.2.3. By Distribution Channel

19. Market Structure Analysis

  • 19.1. Market Analysis, by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Branding and Promotional Strategies
  • 20.3. Key Development Analysis
  • 20.4. Competition Deep Dive
    • 20.4.1. Novartis AG (Liposoma BV)
      • 20.4.1.1. Overview
      • 20.4.1.2. Product Portfolio
      • 20.4.1.3. Sales Footprint
      • 20.4.1.4. Key Financials
      • 20.4.1.5. SWOT Analysis
      • 20.4.1.6. Strategy Overview
        • 20.4.1.6.1. Marketing Strategy
        • 20.4.1.6.2. Product Strategy
        • 20.4.1.6.3. Channel Strategy
    • 20.4.2. Precision NanoSystems Inc
      • 20.4.2.1. Overview
      • 20.4.2.2. Product Portfolio
      • 20.4.2.3. Sales Footprint
      • 20.4.2.4. Key Financials
      • 20.4.2.5. SWOT Analysis
      • 20.4.2.6. Strategy Overview
        • 20.4.2.6.1. Marketing Strategy
        • 20.4.2.6.2. Product Strategy
        • 20.4.2.6.3. Channel Strategy
    • 20.4.3. Janssen Pharmaceutical Companies (Johnson & Johnson)
      • 20.4.3.1. Overview
      • 20.4.3.2. Product Portfolio
      • 20.4.3.3. Sales Footprint
      • 20.4.3.4. Key Financials
      • 20.4.3.5. SWOT Analysis
      • 20.4.3.6. Strategy Overview
        • 20.4.3.6.1. Marketing Strategy
        • 20.4.3.6.2. Product Strategy
        • 20.4.3.6.3. Channel Strategy
    • 20.4.4. Encapsula Nano Sciences
      • 20.4.4.1. Overview
      • 20.4.4.2. Product Portfolio
      • 20.4.4.3. Sales Footprint
      • 20.4.4.4. Key Financials
      • 20.4.4.5. SWOT Analysis
      • 20.4.4.6. Strategy Overview
        • 20.4.4.6.1. Marketing Strategy
        • 20.4.4.6.2. Product Strategy
        • 20.4.4.6.3. Channel Strategy
    • 20.4.5. Synpac-Kingdom Pharmaceutical Co., Ltd
      • 20.4.5.1. Overview
      • 20.4.5.2. Product Portfolio
      • 20.4.5.3. Sales Footprint
      • 20.4.5.4. Key Financials
      • 20.4.5.5. SWOT Analysis
      • 20.4.5.6. Strategy Overview
        • 20.4.5.6.1. Marketing Strategy
        • 20.4.5.6.2. Product Strategy
        • 20.4.5.6.3. Channel Strategy
    • 20.4.6. Celsion GmbH
      • 20.4.6.1. Overview
      • 20.4.6.2. Product Portfolio
      • 20.4.6.3. Sales Footprint
      • 20.4.6.4. Key Financials
      • 20.4.6.5. SWOT Analysis
      • 20.4.6.6. Strategy Overview
        • 20.4.6.6.1. Marketing Strategy
        • 20.4.6.6.2. Product Strategy
        • 20.4.6.6.3. Channel Strategy
    • 20.4.7. Gilead Sciences, Inc
      • 20.4.7.1. Overview
      • 20.4.7.2. Product Portfolio
      • 20.4.7.3. Sales Footprint
      • 20.4.7.4. Key Financials
      • 20.4.7.5. SWOT Analysis
      • 20.4.7.6. Strategy Overview
        • 20.4.7.6.1. Marketing Strategy
        • 20.4.7.6.2. Product Strategy
        • 20.4.7.6.3. Channel Strategy
    • 20.4.8. Pacira BioSciences, Inc.
      • 20.4.8.1. Overview
      • 20.4.8.2. Product Portfolio
      • 20.4.8.3. Sales Footprint
      • 20.4.8.4. Key Financials
      • 20.4.8.5. SWOT Analysis
      • 20.4.8.6. Strategy Overview
        • 20.4.8.6.1. Marketing Strategy
        • 20.4.8.6.2. Product Strategy
        • 20.4.8.6.3. Channel Strategy
    • 20.4.9. Luye Pharma Group
      • 20.4.9.1. Overview
      • 20.4.9.2. Product Portfolio
      • 20.4.9.3. Sales Footprint
      • 20.4.9.4. Key Financials
      • 20.4.9.5. SWOT Analysis
      • 20.4.9.6. Strategy Overview
        • 20.4.9.6.1. Marketing Strategy
        • 20.4.9.6.2. Product Strategy
        • 20.4.9.6.3. Channel Strategy
    • 20.4.10. Sun Pharma Industries Ltd
      • 20.4.10.1. Overview
      • 20.4.10.2. Product Portfolio
      • 20.4.10.3. Sales Footprint
      • 20.4.10.4. Key Financials
      • 20.4.10.5. SWOT Analysis
      • 20.4.10.6. Strategy Overview
        • 20.4.10.6.1. Marketing Strategy
        • 20.4.10.6.2. Product Strategy
        • 20.4.10.6.3. Channel Strategy
    • 20.4.11. Shanghai New Asia Pharmaceutical Co., Ltd.
      • 20.4.11.1. Overview
      • 20.4.11.2. Product Portfolio
      • 20.4.11.3. Sales Footprint
      • 20.4.11.4. Key Financials
      • 20.4.11.5. SWOT Analysis
      • 20.4.11.6. Strategy Overview
        • 20.4.11.6.1. Marketing Strategy
        • 20.4.11.6.2. Product Strategy
        • 20.4.11.6.3. Channel Strategy
    • 20.4.12. ENERGY DELIVERY SOLUTIONs
      • 20.4.12.1. Overview
      • 20.4.12.2. Product Portfolio
      • 20.4.12.3. Sales Footprint
      • 20.4.12.4. Key Financials
      • 20.4.12.5. SWOT Analysis
      • 20.4.12.6. Strategy Overview
        • 20.4.12.6.1. Marketing Strategy
        • 20.4.12.6.2. Product Strategy
        • 20.4.12.6.3. Channel Strategy
    • 20.4.13. Creative Biolabs
      • 20.4.13.1. Overview
      • 20.4.13.2. Product Portfolio
      • 20.4.13.3. Sales Footprint
      • 20.4.13.4. Key Financials
      • 20.4.13.5. SWOT Analysis
      • 20.4.13.6. Strategy Overview
        • 20.4.13.6.1. Marketing Strategy
        • 20.4.13.6.2. Product Strategy
        • 20.4.13.6.3. Channel Strategy
    • 20.4.14. Nanovex Biotechnologies SL
      • 20.4.14.1. Overview
      • 20.4.14.2. Product Portfolio
      • 20.4.14.3. Sales Footprint
      • 20.4.14.4. Key Financials
      • 20.4.14.5. SWOT Analysis
      • 20.4.14.6. Strategy Overview
        • 20.4.14.6.1. Marketing Strategy
        • 20.4.14.6.2. Product Strategy
        • 20.4.14.6.3. Channel Strategy
    • 20.4.15. Insys Therapeutics Inc
      • 20.4.15.1. Overview
      • 20.4.15.2. Product Portfolio
      • 20.4.15.3. Sales Footprint
      • 20.4.15.4. Key Financials
      • 20.4.15.5. SWOT Analysis
      • 20.4.15.6. Strategy Overview
        • 20.4.15.6.1. Marketing Strategy
        • 20.4.15.6.2. Product Strategy
        • 20.4.15.6.3. Channel Strategy
    • 20.4.16. Fujifilm Holdings Corporation
      • 20.4.16.1. Overview
      • 20.4.16.2. Product Portfolio
      • 20.4.16.3. Sales Footprint
      • 20.4.16.4. Key Financials
      • 20.4.16.5. SWOT Analysis
      • 20.4.16.6. Strategy Overview
        • 20.4.16.6.1. Marketing Strategy
        • 20.4.16.6.2. Product Strategy
        • 20.4.16.6.3. Channel Strategy
    • 20.4.17. Virpax Pharmaceuticals
      • 20.4.17.1. Overview
      • 20.4.17.2. Product Portfolio
      • 20.4.17.3. Sales Footprint
      • 20.4.17.4. Key Financials
      • 20.4.17.5. SWOT Analysis
      • 20.4.17.6. Strategy Overview
        • 20.4.17.6.1. Marketing Strategy
        • 20.4.17.6.2. Product Strategy
        • 20.4.17.6.3. Channel Strategy
    • 20.4.18. Azaya Therapeutics
      • 20.4.18.1. Overview
      • 20.4.18.2. Product Portfolio
      • 20.4.18.3. Sales Footprint
      • 20.4.18.4. Key Financials
      • 20.4.18.5. SWOT Analysis
      • 20.4.18.6. Strategy Overview
        • 20.4.18.6.1. Marketing Strategy
        • 20.4.18.6.2. Product Strategy
        • 20.4.18.6.3. Channel Strategy
    • 20.4.19. Avanti Polar Lipids, Inc.
      • 20.4.19.1. Overview
      • 20.4.19.2. Product Portfolio
      • 20.4.19.3. Sales Footprint
      • 20.4.19.4. Key Financials
      • 20.4.19.5. SWOT Analysis
      • 20.4.19.6. Strategy Overview
        • 20.4.19.6.1. Marketing Strategy
        • 20.4.19.6.2. Product Strategy
        • 20.4.19.6.3. Channel Strategy
    • 20.4.20. Breath Therapeutics (Zambon company)
      • 20.4.20.1. Overview
      • 20.4.20.2. Product Portfolio
      • 20.4.20.3. Sales Footprint
      • 20.4.20.4. Key Financials
      • 20.4.20.5. SWOT Analysis
      • 20.4.20.6. Strategy Overview
        • 20.4.20.6.1. Marketing Strategy
        • 20.4.20.6.2. Product Strategy
        • 20.4.20.6.3. Channel Strategy
    • 20.4.21. Getwell
      • 20.4.21.1. Overview
      • 20.4.21.2. Product Portfolio
      • 20.4.21.3. Sales Footprint
      • 20.4.21.4. Key Financials
      • 20.4.21.5. SWOT Analysis
      • 20.4.21.6. Strategy Overview
        • 20.4.21.6.1. Marketing Strategy
        • 20.4.21.6.2. Product Strategy
        • 20.4.21.6.3. Channel Strategy
    • 20.4.22. Taiwan Liposome Company Ltd
      • 20.4.22.1. Overview
      • 20.4.22.2. Product Portfolio
      • 20.4.22.3. Sales Footprint
      • 20.4.22.4. Key Financials
      • 20.4.22.5. SWOT Analysis
      • 20.4.22.6. Strategy Overview
        • 20.4.22.6.1. Marketing Strategy
        • 20.4.22.6.2. Product Strategy
        • 20.4.22.6.3. Channel Strategy
    • 20.4.23. Fresenius Health Care Group
      • 20.4.23.1. Overview
      • 20.4.23.2. Product Portfolio
      • 20.4.23.3. Sales Footprint
      • 20.4.23.4. Key Financials
      • 20.4.23.5. SWOT Analysis
      • 20.4.23.6. Strategy Overview
        • 20.4.23.6.1. Marketing Strategy
        • 20.4.23.6.2. Product Strategy
        • 20.4.23.6.3. Channel Strategy
    • 20.4.24. Xellia Pharmaceuticals (Novo Holdings A/S)
      • 20.4.24.1. Overview
      • 20.4.24.2. Product Portfolio
      • 20.4.24.3. Sales Footprint
      • 20.4.24.4. Key Financials
      • 20.4.24.5. SWOT Analysis
      • 20.4.24.6. Strategy Overview
        • 20.4.24.6.1. Marketing Strategy
        • 20.4.24.6.2. Product Strategy
        • 20.4.24.6.3. Channel Strategy
    • 20.4.25. Jazz Pharmaceuticals plc
      • 20.4.25.1. Overview
      • 20.4.25.2. Product Portfolio
      • 20.4.25.3. Sales Footprint
      • 20.4.25.4. Key Financials
      • 20.4.25.5. SWOT Analysis
      • 20.4.25.6. Strategy Overview
        • 20.4.25.6.1. Marketing Strategy
        • 20.4.25.6.2. Product Strategy
        • 20.4.25.6.3. Channel Strategy
    • 20.4.26. Ipsen Biopharmaceuticals, Inc.
      • 20.4.26.1. Overview
      • 20.4.26.2. Product Portfolio
      • 20.4.26.3. Sales Footprint
      • 20.4.26.4. Key Financials
      • 20.4.26.5. SWOT Analysis
      • 20.4.26.6. Strategy Overview
        • 20.4.26.6.1. Marketing Strategy
        • 20.4.26.6.2. Product Strategy
        • 20.4.26.6.3. Channel Strategy
    • 20.4.27. Baxter
      • 20.4.27.1. Overview
      • 20.4.27.2. Product Portfolio
      • 20.4.27.3. Sales Footprint
      • 20.4.27.4. Key Financials
      • 20.4.27.5. SWOT Analysis
      • 20.4.27.6. Strategy Overview
        • 20.4.27.6.1. Marketing Strategy
        • 20.4.27.6.2. Product Strategy
        • 20.4.27.6.3. Channel Strategy
    • 20.4.28. GMPriority Pharma
      • 20.4.28.1. Overview
      • 20.4.28.2. Product Portfolio
      • 20.4.28.3. Sales Footprint
      • 20.4.28.4. Key Financials
      • 20.4.28.5. SWOT Analysis
      • 20.4.28.6. Strategy Overview
        • 20.4.28.6.1. Marketing Strategy
        • 20.4.28.6.2. Product Strategy
        • 20.4.28.6.3. Channel Strategy
    • 20.4.29. S. G. Biopharm Pvt. Ltd
      • 20.4.29.1. Overview
      • 20.4.29.2. Product Portfolio
      • 20.4.29.3. Sales Footprint
      • 20.4.29.4. Key Financials
      • 20.4.29.5. SWOT Analysis
      • 20.4.29.6. Strategy Overview
        • 20.4.29.6.1. Marketing Strategy
        • 20.4.29.6.2. Product Strategy
        • 20.4.29.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology